Treatment can do more harm than good for prostate cancer − why active surveillance may be a better option for some

People with low-risk prostate cancer are more likely to die from something else. Overdiagnosis and overtreatment can lead to life-changing complications.

Jinping Xu, Chair of Family Medicine and Public Health Sciences, Wayne State University • conversation
Jan. 26, 2024 ~10 min

Prostate cancer treatment is not always the best option – a cancer researcher walks her father through his diagnosis

Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.

Luisel Ricks-Santi, Associate Professor of Pharmacy, University of Florida • conversation
Aug. 8, 2023 ~10 min


Every cancer is unique – why different cancers require different treatments, and how evolution drives drug resistance

There is no one-size-fits-all approach to treating cancer. Understanding how cancer cells evolve could help researchers develop more effective drugs.

Monika Joshi, Associate Professor of Hematology and Oncology, Penn State • conversation
May 1, 2023 ~10 min

Lung cancer rates have decreased for the Marlboro Man, but have risen steeply for nonsmokers and young women – an oncologist explains why

While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.

Estelamari Rodriguez, Associate Director of Community Outreach in Thoracic Oncology, University of Miami • conversation
Feb. 1, 2023 ~7 min

Doctors often aren’t trained on the preventive health care needs of gender-diverse people – as a result, many patients don’t get the care they need

From primary care to cancer screening and insurance coverage, gender-diverse people still face many hurdles to getting good medical care.

Jenna Sizemore, Assistant Professor of Medicine, West Virginia University • conversation
Nov. 14, 2022 ~10 min

A blood test that screens for multiple cancers at once promises to boost early detection

Multicancer early detection tests are among the priorities of the Biden administration’s Cancer Moonshot. The tests show promise, but questions remain about when and how to use them.

Colin Pritchard, Professor of Laboratory Medicine and Pathology, University of Washington • conversation
Oct. 31, 2022 ~8 min

Biopsies confirm a breast cancer diagnosis after an abnormal mammogram – but structural racism may lead to lengthy delays

Early detection of breast cancer is critical to improving chances of survival. But racial and ethnic minority patients systematically have delayed diagnoses that reduce the benefits of screening.

Christoph Lee, Professor of Radiology, School of Medicine, University of Washington • conversation
July 8, 2022 ~7 min

Ovarian cancer is not a silent killer – recognizing its symptoms could help reduce misdiagnosis and late detection

There are currently no effective tests to screen for ovarian cancer. But that doesn’t mean there aren’t ways to recognize and prevent it.

Barbara Goff, Professor of Obstetrics and Gynecology, University of Washington • conversation
April 25, 2022 ~6 min


The next attack on the Affordable Care Act may cost you free preventive health care

The Affordable Care Act has allowed many preventive health services, including cancer screenings and vaccines, to be free of charge. But legal challenges may lead to costly repercussions for patients.

Alex Hoagland, PhD Candidate in Health Economics, Boston University • conversation
Sept. 7, 2021 ~9 min

Experts lower recommended age for colorectal cancer screening

Experts lower the recommended age for colorectal cancer screening.

Harvard Gazette • harvard
May 18, 2021 ~6 min

/

1